Log in
Pharmacology

Cardiovascular Drugs

57 topics with concise reviews: definitions, key facts, and class questions.

This section covers the pharmacology of drugs used to treat arterial hypertension, coronary artery disease (CAD), and heart failure. The study begins with fundamentals — the physiological mechanisms of blood pressure regulation and myocardial contraction, allowing a smooth transition to drug mechanisms of action.

Material is grouped by major clinical tasks. You will study antihypertensive agents of all lines (from ACE inhibitors, ARBs, and diuretics to centrally acting and myotropic drugs), antianginal drugs (organic nitrates, calcium channel blockers, beta-blockers), and cardiotonics (cardiac glycosides and non-glycoside drugs). Also included are agents for cerebral circulation disorders and hypertensive agents.

What is most frequently asked in class and exams? Traditional "hits" include the mechanisms of action and adverse effects of RAAS blockers (captopril, enalapril, losartan), the fundamental differences between dihydropyridine calcium antagonists (amlodipine) and cardioselective ones (verapamil), as well as the symptoms and emergency care for digitalis toxicity. Be sure to note the principles of modern pharmacotherapy for acute coronary syndrome and CHF — this is the foundation of clinical thinking.

Section Topics

Mechanism of action of blockersThe mechanism of action of blockers consists in pharmacodynamic interactionCoronary artery disease: coronary circulatory insufficiencyCoronary artery disease is accompanied by a critical imbalance betweenOrganic nitratesOrganic nitrates are a class of antianginal agents thatIsosorbide dinitrateIsosorbidi dinitrasIsosorbide mononitrateIsosorbidi mononitrasMolsidomineMolsidominumCalcium channel blockersCalcium channel blockers (CCBs) represent a group of pharmacologicalVerapamilVerapamilumDiltiazemDiltiazemumNifedipineNifedipinumAmlodipineAmlodipinumBeta-blockers in CADBeta-blockers serve as the drugs of choice and first-line therapyIvabradineIvabradinumDipyridamoleDipyridamolumValidolValidolumTrimetazidineTrimetazidinumPharmacotherapy of acute coronary syndromeAcute coronary syndrome unites conditions ranging from unstable anginaAntihypertensive agentsAntihypertensive agents are an extensive group of pharmacologicalPhysiological mechanisms of blood pressure regulationThe main compensatory mechanism for maintaining normal arterialCentrally acting antihypertensive agentsCentrally acting antihypertensive agents lower blood pressureGuanfacineGuanfacinumMethyldopaMethyldopumMoxonidineMoxonidinumAlpha, beta-blockersAlpha, beta-blockers are a pharmacological group of drugsAlpha-blockersAlpha-blockers are a group of neurotropic antihypertensivePrazosinPrazosinumDoxazosinDoxazosinumAgents reducing renin-angiotensin system activityDrugs suppressing the renin-angiotensin-aldosterone system (RAAS)CaptoprilCaptoprilumEnalaprilEnalaprilumVasopeptidase inhibitorsVasopeptidase inhibitors represent a class of pharmacological agentsAngiotensin II receptor blockersAngiotensin II receptor blockers (ARBs) are a modern pharmacoLosartanLosartanumIrbesartanIrbesartanumMyotropic antihypertensive agentsMyotropic antihypertensive agents lower blood pressureCalcium channel blockers (Amlodipine, Nifedipine)Amlodipinum, NifedipinumPotassium channel activatorsMinoxidil, DiazoxideSodium nitroprussideNatrii nitroprussidumHydralazine and dihydralazineHydralazinum, DihydralazinumNatriuretic peptides and their agonistsNesiritidumVasopressin and endothelin antagonistsTezosentanDiuretics in the treatment of arterial hypertensionIndapamidumCombination antihypertensive agentsCombination antihypertensive agents are drugs containingImidazoline receptor agonistsImidazoline receptor agonists are a group of hypotensive drugsHypertensive agentsAngiotensinamidumTachycardia as an adverse effectAn increase in heart rate is a common undesirableMechanisms of the hypotensive action of drugsThe hypotensive effect of medicinal products is realized through a decreasePhysiology of myocardial contractionCardiac muscle contraction is based on the strict management of calcium ionsDigoxinDigoxinumStrophanthin and corglyconStrophanthinumDigitalis toxicityDigitalis toxicity develops due to the tendency of cardiac glycosidesNon-glycoside cardiotonicsNon-glycoside cardiotonics represent a pharmacological groupChronic heart failureChronic heart failure represents a progressivePharmacotherapy of chronic heart failureMedical treatment of chronic congestive heart failurePharmacotherapy of acute heart failurePharmacotherapy of acute heart failure (AHF) is a system of emergencyAgents for cerebral circulation disordersCerebral circulation disorders are divided into acute and chronic formsMechanism of action of inhibitorsInhibitors are pharmacological compounds that block the activity

Frequently asked questions for this section

What is the essence of the pharmacodynamic interaction of blockers?

It is realized at the level of the mechanism of action and effect, rather than substance concentration. Usually, this is competition between stimulators (agonists) and blockers (antagonists) for the same receptors.

Why can vessels not provide blood flow during physical exertion in atherosclerosis?

Distal to the atherosclerotic plaque, vessels are already in a state of maximum dilation due to tissue hypoxia and adenosine accumulation. There is simply no reserve for further dilation when oxygen demand increases.

Why is nitroglycerin placed under the tongue during an attack instead of being swallowed?

Upon sublingual administration, the drug is absorbed into the systemic circulation, bypassing the liver. If the tablet is swallowed, about 40% of the substance is inactivated during the "first pass" through the liver, and the effect will occur too late.

What is the difference between sublingual and oral routes of administration?

With sublingual administration, the onset is faster (in 2–5 minutes) with a bioavailability of 60%. Oral administration yields an effect in 15–40 minutes, and bioavailability drops to 20% due to first-pass hepatic metabolism.

To which pharmacological group does Isosorbide mononitrate belong?

The drug belongs to the class of organic nitrates and is an active metabolite of isosorbide dinitrate (isosorbide-5-mononitrate).

Why is the drug not used for the emergency relief of an angina attack?

Because it is a prodrug. It requires time for gastrointestinal absorption (bioavailability 60–70%) and multi-step hepatic metabolism to form active metabolites SIN-1 and SIN-1A, which release NO. The main purpose of the drug is prophylaxis.

Master the entire topic in the «Pharmacology» course

This is a summary. The course covers everything tested in classes and exams.

  • 5,304 pages of study guides on all topics
  • Assignments and quizzes after every topic — just like in a colloquium
  • AI tutor answers questions on the topic anytime
  • 116 video lessons on the subject
All sections of the subject "Pharmacology"